Search information pages
About Alzheimer's Research & Therapy
This page includes information about the aims and scope of Alzheimer's Research & Therapy, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.
Aims & scope
Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports. Although the primary focus is Alzheimer's dementia, the scope encompasses translational research into other neurodegenerative diseases.
All Research articles and Open comments articles published by Alzheimer's Research & Therapy are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here. In addition, the journal also publishes reviews and other article types that are only available by subscription.
Authors of Research articles and Open comments articles published in Alzheimer's Research & Therapy are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.
For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
In addition to research articles Alzheimer's Research & Therapy also publishes Commentaries, Debates, Meeting reports, Reviews and Viewpoints all of which are only available by subscription. BioMed Central holds the copyright to such subscription content according to the terms of BioMed Central's Copyright Licensing Agreement.
Open access publishing is not without costs. Alzheimer's Research & Therapy therefore levies an article-processing charge of £1325/$2215/€1600 for each Research articles and Open comments article accepted for publication. We routinely waive charges for authors from low-income countries. Generally, if the submitting author's institution is a Member the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. For further details, see our article-processing charge page. A limited number of waivers for article-processing charges are also available at the editors' discretion, and authors wishing to apply for these waivers should contact the editors.
All articles published in Alzheimer's Research & Therapy are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in Alzheimer's Research & Therapy include:
- Current contents
- Journal Citation Reports/Science Edition
- PubMed Central
- Science Citation Index Expanded
The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including e-Depot (The Netherlands).
The full text of all research articles published by BioMed Central is also available on SpringerLink.
Alzheimer's Research & Therapy is tracked by Thomson Reuters (ISI) and has an Impact Factor of 4.39.
Publication and peer review process
Criteria for publication
Research articles: reports of data from exceptional original research. These articles will form the major content of the journal.
Reviews: provide a factual account of recent developments within an area of research. Most are commissioned, though suggestions of topics are always welcome. In-depth reviews provide substantial coverage of a subject in a single longer article, and multi-author thematic series explore a subject in a series of concise, narrowly focused review articles coordinated by a leading authority in the field.
Commentaries: short, focused and opinionated articles of contemporary interest on any subject within the journal's scope. Most are commissioned, although unsolicited commentaries are welcome and are routinely peer reviewed.
Letters: may discuss material published in Alzheimer's Research & Therapy or particular issues of general interest to the readership. They may also present a community announcement within the field.
Meeting Reports: short descriptions of a conference that an author has attended, which should focus on the key developments presented and discussed at the meeting. These articles are usually commissioned but reports and suggestions may also be submitted for the editors' consideration.
Viewpoints: short opinion pieces focusing on the latest high-impact research.
Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Alzheimer's Research & Therapy, a personalized section of the site.
Copyediting and proofs
All articles published in Alzheimer's Research & Therapy are copyedited before publication of the final version.
Research articles and Open comments articles published in Alzheimer's Research & Therapy are published immediately on acceptance in the form of a provisional PDF. Copyedited and fully formatted PDF and full-text (HTML) versions are made available shortly after that.
Edited versions will be sent by email and corrections should be returned within two working days. Please provide a typed list of corrections clearly indicating where the corrections should be made and please send this list by email.
The editing of Research articles and Open comments articles is designed only to correct such things as misused words, spelling errors, missing references or incomplete citation information.
High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.
Alzheimer's Research & Therapy will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.
All manuscripts submitted to Alzheimer's Research & Therapy should adhere to BioMed Central's editorial policies.
Citing articles in Alzheimer's Research & Therapy
Articles in Alzheimer's Research & Therapy should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Alzheimers Res Ther [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Alzheimers Res Ther 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Why publish your article in Alzheimer's Research & Therapy?
Alzheimer's Research & Therapy's open access policy allows maximum visibility of research articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.
Speed of publication
Alzheimer's Research & Therapy offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Alzheimer's Research & Therapy, BioMed Central and PubMed Central and will also be included in PubMed.
Online publication in Alzheimer's Research & Therapy gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Alzheimer's Research & Therapy are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Alzheimer's Research & Therapy's pages and on the BioMed Central homepage.
In addition, articles published in Alzheimer's Research & Therapy may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Alzheimer's Research & Therapy. A list of articles recently press-released by journals published by BioMed Central is available here.
Authors of research articles published in Alzheimer's Research & Therapy retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright and license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.